IBIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
IBIO, INC. (IBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 637.19 thousand shares for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-27.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-09-27
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was 21.51K shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 5.58K shares, a 99.55% decline year-over-year.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-06-30 was 0.00 shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 1.24M shares, a 2378.30% increase year-over-year.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 637.19K shares, a 2019.17% increase from fiscal 2022.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 30.07K shares, a 526.68% increase from fiscal 2021.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 4.80K shares, a 95.82% decline from fiscal 2020.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 114.65K shares, a 91.13% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 24 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | 637.19K shares 10-K · filed 2023-09-27 | |||||
| 2022-06-30 | 30.07K shares 10-K · filed 2023-09-27 | |||||
| 2021-06-30 | 4.80K shares 10-K · filed 2022-10-11 | 119.93K shares 10-K · filed 2021-09-28 | ||||
| 2020-06-30 | 21.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | 27.09K shares derived: sum of 2 quarters · filed 2021-09-28 | 114.65K shares 10-K · filed 2021-09-28 | |||
| 2020-03-31 | 5.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | 93.15K shares 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | 87.56K shares 10-Q · filed 2020-02-14 | |||||
| 2019-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | 1.24M shares derived: sum of 2 quarters · filed 2019-08-26 | 1.29M shares derived: sum of 3 quarters · filed 2019-08-26 | 1.29M shares 10-K · filed 2019-08-26 | 1.29M shares 10-K · filed 2020-10-13 | |
| 2019-03-31 | 1.24M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | 1.29M shares derived: sum of 2 quarters · filed 2019-05-10 | 1.29M shares 10-Q · filed 2019-05-10 | 1.21M shares derived: sum of 4 quarters · filed 2019-08-26 | ||
| 2018-12-31 | 52.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | 53.25K shares 10-Q · filed 2019-02-13 | -28.00K shares derived: sum of 3 quarters · filed 2019-08-26 | 22.00K shares derived: sum of 4 quarters · filed 2019-08-26 | ||
| 2018-09-30 | 833.00 shares 10-Q · filed 2018-11-13 | -80.42K shares derived: sum of 2 quarters · filed 2019-08-26 | -30.42K shares derived: sum of 3 quarters · filed 2019-08-26 | |||
| 2018-06-30 | -81.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | -31.25K shares derived: sum of 2 quarters · filed 2019-08-26 | 11.25K shares 10-K · filed 2019-08-26 | |||
| 2018-03-31 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-11 | 92.50K shares 10-Q · filed 2018-05-11 | ||||
| 2017-12-31 | 42.50K shares 10-Q · filed 2018-02-14 | |||||
| 2017-06-30 | -85.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | 31.00K shares 10-K · filed 2018-09-18 | 310.00K shares 10-K · filed 2017-09-15 | |||
| 2017-03-31 | 116.67K shares 10-Q · filed 2017-05-15 | |||||
| 2016-06-30 | 0.00 shares 10-K · filed 2017-09-15 | |||||
| 2015-06-30 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 200.00K shares derived: sum of 2 quarters · filed 2016-10-13 | 700.00K shares 10-K · filed 2016-10-13 | |||
| 2015-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | 500.00K shares 10-Q · filed 2015-05-15 | ||||
| 2014-12-31 | 500.00K shares 10-Q · filed 2015-02-24 | |||||
| 2014-06-30 | 266.67K shares 10-K · filed 2015-10-13 | |||||
| 2013-06-30 | 160.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | 160.00K shares derived: sum of 2 quarters · filed 2014-09-29 | 80.00K shares 10-K · filed 2014-09-29 | |||
| 2013-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | -80.00K shares 10-Q · filed 2013-05-20 | ||||
| 2012-12-31 | -80.00K shares 10-Q · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |